Cargando…
An atypical ALS with PSP-like symptoms caused by ANXA11 p.D40G mutation: A case report and literature review
BACKGROUND: ANXA11 mutations were first reported to be associated with amyotrophic lateral sclerosis (ALS) in 2017. Several studies have investigated the prevalence of ANXA11 mutations in different populations, while less is known about the spectrum of phenotypes and the genotype–phenotype correlati...
Autores principales: | Zhang, Xin, Gao, Juan, Chi, Chunling, Zhao, Zhenzhen, Chan, Piu, Ma, Jinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978770/ https://www.ncbi.nlm.nih.gov/pubmed/36873447 http://dx.doi.org/10.3389/fneur.2023.1086264 |
Ejemplares similares
-
Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020) -
ANXA11 mutations are associated with amyotrophic lateral sclerosis–frontotemporal dementia
por: Wang, Yu, et al.
Publicado: (2022) -
Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants
por: Natera‐de Benito, Daniel, et al.
Publicado: (2023) -
DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021) -
Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?
por: Sánchez-Ruiz de Gordoa, Javier, et al.
Publicado: (2022)